Kelyniam Global, Inc. (KLYG)
OTCMKTS
· Delayed Price · Currency is USD
0.1800
+0.0391 (27.75%)
May 14, 2025, 9:35 AM EDT
Kelyniam Global Revenue
In the year 2023, Kelyniam Global had annual revenue of $2.67M, down -11.44%. Kelyniam Global had revenue of $930.77K in the quarter ending December 31, 2023, with 14.08% growth.
Revenue
2.67M
Revenue Growth
-8.03%
P/S Ratio
3.35
Revenue / Employee
133.62K
Employees
20
Market Cap
8.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.67M | -345.24K | -11.44% |
Dec 31, 2022 | 3.02M | 353.17K | 13.25% |
Dec 31, 2021 | 2.66M | 152.33K | 6.06% |
Dec 31, 2020 | 2.51M | 328.98K | 15.07% |
Dec 31, 2019 | 2.18M | 59.43K | 2.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Kelyniam Global News
- 3 days ago - Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership - PRNewsWire
- 2 months ago - KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024 - PRNewsWire
- 5 months ago - Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering - PRNewsWire
- 6 months ago - Kelyniam Global Releases Q3 Financials, Strong Performance Continues - PRNewsWire
- 9 months ago - Kelyniam Global Releases Strong Q2 Financials - PRNewsWire
- 1 year ago - Kelyniam Global Releases Q1 Financials - PRNewsWire
- 1 year ago - NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use - PRNewsWire
- 1 year ago - Strong Fourth Quarter Powers 2023 Kelyniam Financials - PRNewsWire